---
title: "3D Systems Rated Hold as Ongoing Profitability Challenges Offset Healthcare Strength and Fair Valuation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286619362.md"
description: "William Blair analyst Brian Drab has maintained a Hold rating on 3D Systems (DDD) due to ongoing profitability challenges despite strong healthcare demand. The company exceeded first-quarter expectations but remains unprofitable on an adjusted basis. With declining organic revenue and compressed gross margins, Drab believes a Hold rating is appropriate. Craig-Hallum also maintained a Hold rating with a $3.00 price target."
datetime: "2026-05-15T20:36:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286619362.md)
  - [en](https://longbridge.com/en/news/286619362.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286619362.md)
---

# 3D Systems Rated Hold as Ongoing Profitability Challenges Offset Healthcare Strength and Fair Valuation

William Blair analyst Brian Drab has maintained their neutral stance on DDD stock, giving a Hold rating on May 13.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Brian Drab has given his Hold rating due to a combination of factors tied to 3D Systems’ mixed fundamental profile. The company modestly exceeded first-quarter expectations, with slightly higher revenue and a return to positive adjusted EBITDA, driven largely by robust healthcare demand, particularly in dental and medical applications. However, despite pockets of strength and early success with platforms like NextDent and metal printing in A&D, the overall growth trajectory has lacked consistency, and the business remains unprofitable on an adjusted basis.

Drab also notes that while management’s cost-cutting initiatives are largely complete and operating expenses should now be stable, the company is still only targeting breakeven adjusted EBITDA for the full year. Organic revenue has declined for several consecutive years, and gross margins have compressed meaningfully, underscoring persistent profitability challenges. Given these headwinds, and with shares appearing fairly valued and near-term upside heavily reliant on a stronger industrial recovery, he believes a Hold rating is appropriate at this stage.

In another report released on May 13, Craig-Hallum also maintained a Hold rating on the stock with a $3.00 price target.

### Related Stocks

- [DDD.US](https://longbridge.com/en/quote/DDD.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)

## Related News & Research

- [3D Systems Q1 adjusted EBITDA turns positive on higher sales volumes](https://longbridge.com/en/news/285999449.md)
- [BUZZ-Dexcom climbs on plans to revamp board panel](https://longbridge.com/en/news/286583878.md)
- [Herbal Dispatch Completes Company Record 500kg Medical Cannabis Export Shipment to Europe | LUFFF Stock News](https://longbridge.com/en/news/286883156.md)
- [embecta Completes Acquisition of Owen Mumford Holdings Limited](https://longbridge.com/en/news/286571686.md)
- [3D Systems Reports First Quarter 2026 Financial Results | DDD Stock News](https://longbridge.com/en/news/285998269.md)